Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
In vivo/preclinical record. PloS one, 2014.
- Animal
- 2014
Authorship
Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.
Source: the abstract of PMID 25412097. Checked Verification: Evidence verified by machine against declared source
This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.
Evidence verified by machine against declared source
Key facts
- Design
- Not reported
- System
- Animal
- Scale
- A total of six mice were studied in each group.
- Comparator
- Present
- Journal
- PloS one
- Year
- 2014
- PMID
- 25412097
- Verification
- Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
- Full-text availability
- Abstract only
Technical summary
Research question
The purpose of this study is to evaluate the whether Tβ4 can be used as a vascular-protective agent.
Study design
To corroborate the in vivo studies, we performed our analysis using lung microvascular endothelial cells (MVEC) stimulated with TGFβ1.
Participants or experimental system
Twelve-week-old male mice (∼25 g) were used for experiments.
Study scale
A total of six mice were studied in each group.
Intervention or exposure
Briefly, wild-type (WT) mice received an intraperitoneal (i.p) injection of MCT (80 mg/kg body wt) every 20 days for 3 times.
Comparator
Age- and sex-matched WT with normal saline-injected mice of C57BL/6 background served as controls.
Outcomes examined
The pathogenesis of MCT-induced PH was evaluated through RV pressure measurement.
Key findings
In monocrotaline (MCT)-induced PH mouse model, we showed that mice treated with Tβ4 significantly attenuated the systolic pressure and RVH, compared to the MCT treated mice.
Not reported in the declared source: Methods.
Limitations and uncertainty
Not reported in the declared source.
Cite
Cite the study
Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Wei C, Kim IK, Li L et al. PloS one. 2014. PMID 25412097
The study and its abstract belong to their authors and publisher. Cite them for anything the study found.
Report an error
If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.
The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.
The report form runs in the interactive page. Open this record with scripts enabled to send a report.
Corrections on this record
No correction has been recorded for this record.
Method sheet
No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.